Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): A randomized clinical trial - Davies, MJ; Bain, SC; Atkin, SL (Diabetes Care, 2016)
doi:10.2337/dc14-2883